Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: A literature review

Keyphrases

• Hormonal Therapy 100%
• Endometrial Adenocarcinoma 100%
• Progestin 75%
• Median Time 50%
• Radiation Chemotherapy 50%
• Uterus 25%
• Histology 25%
• Tumor 25%
• English Language 25%
• Radiation Therapy 25%
• Carcinoma 25%
• Endometrial Cancer 25%
• Polyps 25%
• Adenocarcinoma 25%
• Recurrence Rate 25%
• Recurrent Disease 25%
• Nineteen 25%
• MEDLINE 25%
• Effective Treatment 25%
• Treatment Regimen 25%
• Hyperplasia 25%
• Progesterone 25%
• Advanced Stage Disease 25%
• Time Response 25%
• Recurring 25%
• Well-differentiated 25%
• Uterine Cancer 25%
• Conservative Treatment 25%
• Conservative Therapy 25%
• Intramuscularly 25%
• Medroxyprogesterone Acetate 25%
• Advanced or Metastatic 25%
• Endometrial Carcinoma 25%
• Megestrol Acetate 25%
• Total Abdominal Hysterectomy 25%
• Chemotherapy Administration 25%
• Ovarian Resection 25%
• Non-endometrioid 25%

Medicine and Dentistry

• Hormone Therapy 100%
• Endometrium Carcinoma 100%
• Gestagen 80%
• Diseases 60%
• Recurrent Disease 60%
• Uterine Cancer 40%
• Conservative Treatment 40%
• Neoplasm 20%
• English (Language) 20%
• Metastatic Carcinoma 20%
• Radiation Therapy 20%
• Carcinoma 20%
• Progesterone 20%
• Polyp 20%
• Adenocarcinoma 20%
• Hyperplasia 20%
• Depo-Provera 20%
• Medroxyprogesterone Acetate 20%
• Wedge Resection 20%
• Megestrol Acetate 20%
• Abdominal Hysterectomy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Hormone Cancer Therapy 100%
• Endometrium Carcinoma 100%
• Progestin 80%
• Diseases 60%
• Recurrent Disease 60%
• Chemotherapy 40%
• Neoplasm 20%
• Metastasis 20%
• Carcinoma 20%
• Progesterone 20%
• Endometrium Cancer 20%
• Polyp 20%
• Adenocarcinoma 20%
• Hyperplasia 20%
• Medroxyprogesterone Acetate 20%
• Uterus Cancer 20%
• Megestrol Acetate 20%